Observational studyBreast cancer (Tokyo, Japan)2021

Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).

Takamichi Yokoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.